Ipamorelin vs CJC-1295 No DAC
Ipamorelin is a selective growth hormone releasing peptide (GHRP) — a pentapeptide that stimulates GH secretion through the ghrelin receptor (GHSR-1a) without significantly affecting cortisol or prolactin, making it one of the most selective GHRPs in research. CJC-1295 No DAC is a growth hormone releasing hormone (GHRH) analogue that stimulates GH release through the GHRH receptor (GHRHR). As a GHRH analogue, CJC-1295 No DAC acts synergistically with GHRPs like Ipamorelin — the combination activates both the GHSR and GHRHR pathways simultaneously, producing additive GH release in preclinical studies. The two compounds are frequently studied together for this reason, though each has distinct individual research applications.
Purity and storage specifications are consistent across all Nexyra Lab lyophilised compounds. Pharmacokinetic data (half-life etc.) is not shown as it requires owner-confirmed verified references. For research planning and laboratory use only.
Other comparisons
For research planning and laboratory use only. Not medical or dosing advice. All products are for research purposes only and not for human or veterinary use.